|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Ultragenyx Pharmaceutical Inc.
| | | Phone: | (415) 483-8800 | Fax: | (415) 483-8810 | Year Established: | 2010 | Ticker: | RARE | Exchange: | NASDAQ | Main Contact: | Thomas Kassberg, Senior VP & CBO | | Other Contacts: | Camille L. Bedrosian, M.D., Executive VP & CMO Shalini Sharp, Executive VP & CFO John Pinion, Executive VP & Chief Quality Operations Officer Karah Parschauer, Executive VP & General Counsel Dennis Huang, Senior VP & Chief Technical Operations Officer Jayson Dallas, M.D., Executive VP & CCO Emil D. Kakkis, M.D., Ph.D.,, President & CEO Wladimir (Vlad) Hogenhuis, M.D., COO
| | Company Description | Ultragenyx is a development-stage biotechnology company committed to bringing to market life-transforming therapeutics for patients with rare and ultra-rare metabolic genetic diseases. The company focuses on diseases for which the unmet medical need is high, the biology for treatment is clear, and for which there are no effective treatments. | |
|
|
|
|
|